Podcast

Podcast: This Week in Managed Care—Next Gen ACO Success and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care stories included encouraging results from the Next Generation Accountable Care Organization model; concerns that CMS' new billing rules will hurt the sickest patients; a study confirms the value of daily aspirin for patients with diabetes.

To listen, login to the website.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

Next Generation ACO Model Saves $62 Million in First Year

Patient, Provider Groups Tell CMS Proposed E/M Service Cuts Will Hurt Sickest Patients

ASCEND Results Confirm Aspirin Prevents Primary Vascular Events in Diabetes

Senate Moves Forward With Drug Price Transparency Amendment

The Financial Impact of the Sequester Cut to Medicare Part B Drug Reimbursement in Community Oncology

Read more about the stories in this podcast:

Related Videos
Mike Fazio, Navista, Cardinal Health
Fran Gregory, PharmD, MBA, sitting for a video interview
Casey Koch, PharmD, sitting for a video interview
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Jaime Almandoz, MD, MBA
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Related Content
Doctor holding generated image of lungs inside a heart | Image credit: Kiattisak - stock.adobe.com
April 28th 2025

PH, PAH Prevalence Higher in Medicaid, With Racial, Ethnic Disparities

Laura Joszt, MA
Medicaid beneficiaries face higher rates of pulmonary hypertension, with significant economic burdens and racial disparities in prevalence and costs.
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
US Tariffs | Image credit: Andrii - stock.adobe.com
April 25th 2025

Trump Tariffs on Pharmaceuticals Risk Causing Higher Costs, Drug Shortages

Pearl Steinzor
The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.
Managed Care Cast Thumbnail
April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Pharmaceuticals | Image credit: psphotography - stock.adobe.com
April 24th 2025

Top Pharmacy Leaders to Convene at Asembia’s AXS25 Summit in Las Vegas

Pearl Steinzor
Asembia's AXS25 Summit will unite more than 8000 key decision-makers to explore pharmacy innovation, artificial intelligence, policy, and patient care from April 27 to May 1 at Wynn & Encore in Las Vegas, Nevada.
Diabetes monitoring | Image credit: abidika - stock.adobe.com
April 23rd 2025

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

Pearl Steinzor
A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 diabetes—but not all obesity-related cancers show a link.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo